Palgyra-125
| Packed: |
125 mg / 21 Capsules |
|---|---|
| Manufacturer: |
Hetero Labs Limited |
| Active ingredient: |
Palbociclib Capsules 125 mg |
Treatment of HR-positive, HER2-negative advanced or metastatic breast cancer in combination with an aromatase inhibitor as primary endocrine therapy in postmenopausal women, or with fulvestrant in women with disease progression after endocrine therapy.
